Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: Focus on individual differences

Pharmacology Biochemistry and Behavior

Volumn 98, Issue 1, 2011, Pages 161-168

  Laugeray, Anthony ^a,b   Launay, Jean Marie ^c   Callebert, Jacques ^c   Surget, Alexandre ^a,b   Belzung, Catherine ^a,b   Barone, Pascal R ^b  

^a CHRU de Tours   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Animal model; Anxiety; Depression; Kynurenine; Mice; Tryptophan; Unpredictable chronic mild stress

Indexed keywords

KYNURENINE; SEROTONIN; TRYPTOPHAN;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CHRONIC STRESS; CINGULATE GYRUS; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; MALE; MAZE TEST; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEROTONIN METABOLISM; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM; UNPREDICTABLE CHRONIC MILD STRESS;

ANIMALIA; MUS;

EID: 78651367055     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.12.008     Document Type: Article

References (62)

1. H. Anisman, S. Hayley, O. Kelly, T. Borowski, and Z. Merali Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes Behav Neurosci 115 2001 443 454
2. N. Barden Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression J Psychiatry Neurosci 29 2004 185 193
3. C. Barkus, S.B. McHugh, R. Sprengel, P.H. Seeburg, J.N. Rawlins, and D.M. Bannerman Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion Eur J Pharmacol 626 2010 49 56
4. S.T. Bland, D. Hargrave, J.L. Pepin, J. Amat, L.R. Watkins, and S.F. Maier Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex Neuropsychopharmacology 28 2003 1589 1596
5. L. Capuron, A. Ravaud, P.J. Neveu, A.H. Miller, M. Maes, and R. Dantzer Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy Mol Psychiatry 7 2002 468 473
6. R. Carpenedo, A. Pittaluga, A. Cozzi, S. Attucci, A. Galli, and M. Raiteri Presynaptic kynurenate-sensitive receptors inhibit glutamate release Eur J Neurosci 13 2001 2141 2147
7. A. Caspi, K. Sugden, T.E. Moffitt, A. Taylor, I.W. Craig, and H. Harrington Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene Science 301 2003 386 389
8. J.H. Connick, and T.W. Stone Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo Br J Pharmacol 93 1988 868 876
9. B.M. Cortese, and K.L. Phan The role of glutamate in anxiety and related disorders CNS Spectr 10 2005 820 830
10. B.M. Cortese, T.R. Mitchell, M.P. Galloway, K.E. Prevost, J. Fang, and G.J. Moore Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior Physiol Behav 99 2010 445 450
11. F. Curtin, and P. Schulz Multiple correlations and Bonferroni's correction Biol Psychiatry 44 1998 775 777
12. G. Curzon, and P.K. Bridges Tryptophan metabolism in depression J Neurol Neurosurg Psychiatry 33 1970 698 704
13. C. Ducottet, G. Griebel, and C. Belzung Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice Prog Neuropsychopharmacol Biol Psychiatry 27 2003 625 631
14. S. Fujigaki, K. Saito, M. Takemura, H. Fujii, H. Wada, and A. Noma Species differences in l-tryptophan-kynurenine pathway metabolism: quantification of anthranilic acid and its related enzymes Arch Biochem Biophys 358 1998 329 335
15. K. Hashimoto Emerging role of glutamate in the pathophysiology of major depressive disorder Brain Res Rev 61 2009 105 123
16. S. Hashimoto, T. Inoue, and T. Koyama Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats Eur J Pharmacol 378 1999 23 30 (Pubitemid 29341559)
17. J.P. Herman, M.M. Ostrander, N.K. Mueller, and H. Figueiredo Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis Prog Neuropsychopharmacol Biol Psychiatry 29 2005 1201 1213
18. M.P. Heyes, and S.P. Markey Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic l-tryptophan administration on brain and blood quinolinic acid concentrations Anal Biochem 174 1988 349 359
19. C. Hilmas, E.F. Pereira, M. Alkondon, A. Rassoulpour, R. Schwarcz, and E.X. Albuquerque The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications J Neurosci 21 2001 7463 7473
20. I.P. Kema, A.M. Schellings, C.J. Hoppenbrouwers, H.M. Rutgers, E.G. de Vries, and F.A. Muskiet High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patients Clin Chim Acta 221 1993 143 158
21. M. Kessler, T. Terramani, G. Lynch, and M. Baudry A glycine site associated with N-methyl-d-aspartic acid receptors: characterization and identification of a new class of antagonists J Neurochem 52 1989 1319 1328
22. J.P. Konsman, P. Parnet, and R. Dantzer Cytokine-induced sickness behaviour: mechanisms and implications Trends Neurosci 25 2002 154 159
23. J.M. Koolhaas Coping style and immunity in animals: making sense of individual variation Brain Behav Immun 22 2008 662 667
24. A. Kugaya, and G. Sanacora Beyond monoamines: glutamatergic function in mood disorders CNS Spectr 10 2005 808 819
25. I.P. Lapin Neurokynurenines (NEKY) as common neurochemical links of stress and anxiety Adv Exp Med Biol 527 2003 121 125
26. R. Lathe The individuality of mice Genes Brain Behav 3 2004 317 327
27. A. Laugeray, J.M. Launay, J. Callebert, A. Surget, C. Belzung, and P.R. Barone Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression Behav Brain Res 210 2010 84 91
28. M. Maes, R. Verkerk, S. Bonaccorso, W. Ombelet, E. Bosmans, and S. Scharpe Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation Life Sci 71 2002 1837 1848
29. S.J. Mathew, R.B. Price, and D.S. Charney Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics Am J Med Genet C Semin Med Genet 148C 2008 89 98
30. H.S. Mayberg Limbic-cortical dysregulation: a proposed model of depression J Neuropsychiatry Clin Neurosci 9 1997 471 481
31. S. Monleon, P. D'Aquila, A. Parra, V.M. Simon, P.F. Brain, and P. Willner Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine Psychopharmacology (Berl) 117 1995 453 457
32. M. Moreau, C. Andre, J.C. O'Connor, S.A. Dumich, J.A. Woods, and K.W. Kelley Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior Brain Behav Immun 22 2008 1087 1095
33. F. Moroni, G. Lombardi, V. Carla, and G. Moneti The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain Brain Res 295 1984 352 355
34. F. Moroni, P. Russi, G. Lombardi, M. Beni, and V. Carla Presence of kynurenic acid in the mammalian brain J Neurochem 51 1988 177 180
35. A.M. Myint, and Y.K. Kim Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression Med Hypotheses 61 2003 519 525
36. A.M. Myint, B.E. Leonard, H.W. Steinbusch, and Y.K. Kim Th1, Th2, and Th3 cytokine alterations in major depression J Affect Disord 88 2005 167 173
37. A.M. Myint, Y.K. Kim, R. Verkerk, S. Scharpe, H. Steinbusch, and B. Leonard Kynurenine pathway in major depression: evidence of impaired neuroprotection J Affect Disord 98 2006 143 151
38. J.C. O'Connor, M.A. Lawson, C. Andre, M. Moreau, J. Lestage, and N. Castanon Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice Mol Psychiatry 14 2008 511 522
39. J.C. O'Connor, C. Andre, Y. Wang, M.A. Lawson, S.S. Szegedi, and J. Lestage Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2, 3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin J Neurosci 29 2009 4200 4209
40. J.C. O'Connor, M.A. Lawson, C. Andre, E.M. Briley, S.S. Szegedi, and J. Lestage Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior J Immunol 182 2009 3202 3212
41. G. Paxinos, and K. Franklin The mouse brain in stereotoxic coordinates 2001 Academic Press San Diego, CA
42. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 14 1985 149 167
43. M.N. Perkins, and T.W. Stone An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid Brain Res 247 1982 184 187
44. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Thér 229 1977 327 336
45. P.F. Renault, J.H. Hoofnagle, Y. Park, K.D. Mullen, M. Peters, and D.B. Jones Psychiatric complications of long-term interferon alfa therapy Arch Intern Med 147 1987 1577 1580
46. A. Rex, C.A. Marsden, and H. Fink Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze Psychopharmacology (Berl) 110 1993 490 496
47. R.J. Rodgers, and N.J. Johnson Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety Pharmacol Biochem Behav 52 1995 297 303
48. R.J. Rodgers, B.J. Cao, A. Dalvi, and A. Holmes Animal models of anxiety: an ethological perspective Braz J Med Biol Res 30 1997 289 304
49. G. Sanacora, C.A. Zarate, J.H. Krystal, and H.K. Manji Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders Nat Rev Drug Discov 7 2008 426 437
50. A.B. Simon, and J.M. Gorman Advances in the treatment of anxiety: targeting glutamate NeuroRx 3 2006 57 68
51. P. Skolnick, P. Popik, and R. Trullas Glutamate-based antidepressants: 20 years on Trends Pharmacol Sci 30 2009 563 569
52. R.S. Smith The macrophage theory of depression Med Hypotheses 35 1991 298 306
53. A. Steptoe, M. Hamer, and Y. Chida The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis Brain Behav Immun 21 2007 901 912
54. A. Surget, Y. Wang, S. Leman, Y. Ibarguen-Vargas, N. Edgar, and G. Griebel Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal Neuropsychopharmacology 34 2009 1363 1380
55. K.J. Swartz, M.J. During, A. Freese, and M.F. Beal Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors J Neurosci 10 1990 2965 2973
56. R.G. Tavares, A.P. Schmidt, J. Abud, C.I. Tasca, and D.O. Souza In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine Neurochem Res 30 2005 439 444
57. J. Vignau, O. Costisella, V. Canva, M. Imbenotte, and A. Duhamel Lhermitte, M Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients Encephale 35 2009 477 483
58. M.C. Wichers, G.H. Koek, G. Robaeys, R. Verkerk, S. Scharpe, and M. Maes IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity Mol Psychiatry 10 2005 538 544
59. B. Widner, A. Laich, B. Sperner-Unterweger, M. Ledochowski, and D. Fuchs Neopterin production, tryptophan degradation, and mental depression-what is the link? Brain Behav Immun 16 2002 590 595
60. P. Willner Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation Psychopharmacology (Berl) 134 1997 319 329
61. H.Q. Wu, E.F. Pereira, J.P. Bruno, R. Pellicciari, E.X. Albuquerque, and R. Schwarcz The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex J Mol Neurosci 40 2009 204 210
62. B.K. Yee, S.W. Zhu, A.H. Mohammed, and J. Feldon Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice J Neural Transm 114 2007 431 444